Our results suggest that p68 is a key molecule involved in the regulation of the expression of the Pkd1 gene and PKD associated miRNAs as well as the activation of PKD regulated signaling pathways, providing a rationale to develop new therapeutic strategies for ADPKD treatment once a p68 inhibitor becomes available. Here, DDX5 is linked to autosomal dominant polycystic kidney disease.